FMF-04-159-2
Cat. No.：YN290215
CAS No. ：2364489-81-4
| 产品名称: | FMF-04-159-2 |
| CAS No.: | 2364489-81-4 |
| Chemical Name: | |
| Synonyms: | (E)-N-(1-((3-(4-(Dimethylamino)but-2-enamido)phenyl)sulfonyl)piperidin-4-yl)-4-(2,4,6-trichlorobenzamido)-1H-pyrazole-3-carboxamide;N-[1-[3-[[(E)-4-(Dimethylamino)but-2-enoyl]amino]phenyl]sulfonylpiperidin-4-yl]-4-[(2,4,6-trichlorob;FMF-04-159-2 |
| 分子量: | 683.01 |
| 分子式: | C₂₈H₃₀Cl₃N₇O₅S |
| SMILES: | O=C(C1=NNC=C1NC(C2=C(Cl)C=C(Cl)C=C2Cl)=O)NC3CCN(S(=O)(C4=CC=CC(NC(/C=C/CN(C)C)=O)=C4)=O)CC3 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | FMF-04-159-2 是一种有效的共价CDK14抑制剂。FMF-04-159-2 抑制 CDK14 和 CDK2，在 NanoBRET 试验中IC50分别为 39.6 nM 和 256 nM。 |
| IC50和靶点: | [{name:"CDK14/Cyclin Y:39.6 nM (IC50, in NanoBRET assay)"},{name: "CDK2:256 nM (IC50, in NanoBRET assay)"}] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
